Neoral and disease progression 
Neoral and disease progression Patient Reports February 11, 2012
Neoral Side Effects Report #4764860-7
Neoral side effect was reported by a Physician from GERMANY on May 02, 2005. Male patient, 65 years of age, weighting 249.1 lb, was diagnosed with renal transplant and was treated with Neoral. After drug was administered, patient experienced the following side effects: cardiac failure, coronary artery atherosclerosis, disease progression, dyspnoea. Neoral dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized. Patient recovered.
Neoral Side Effects Report #4561202-7
Neoral side effect was reported by a Consumer or non-health professional from on Dec 02, 2004. Female patient, 52 years of age, weighting 147.7 lb, was diagnosed with renal transplant and was treated with Neoral. After drug was administered, patient experienced the following side effects: aspiration, cytomegalovirus infection
, disease progression, diverticulitis, gastrointestinal haemorrhage, graft dysfunction, graft infection, graft loss, herpes simplex . Neoral dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized and became disabled. Patient recovered.Neoral Side Effects Report #4726147-8
Neoral side effect was reported by a Consumer or non-health professional from CZECH REPUBLIC on Dec 02, 2004. Female patient, 52 years of age, weighting 147.7 lb, was diagnosed with renal transplant and was treated with Neoral. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, disease progression, diverticulitis, gastrointestinal haemorrhage, graft dysfunction, graft infection, herpes simplex , hypotension, large intestine perforation. Neoral dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized and became disabled. Patient died on 06/28/2005.Neoral Side Effects Report #5915239-3
Neoral side effect was reported by a Physician from FRANCE on Oct 01, 2008. Male patient, weighting 211.6 lb, was diagnosed with renal transplant and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood creatinine increased, complications of transplanted kidney, disease progression, glomerular vascular disorder, kidney fibrosis, renal tubular atrophy, ureteric stenosis. Neoral dosage: 125 MG, BID. During the same period patient was treated with ERL, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.
Neoral Side Effects Report #4816483-9
Neoral side effect was reported by a Consumer or non-health professional from FRANCE on Oct 21, 2005. Male patient, 51 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Neoral. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, disease progression, haemodialysis, hypoxia, kidney transplant rejection, pneumonia
, pneumonia bacterial, renal impairment. Neoral dosage: 75 MG 2X PER 1 DAY, ORAL. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, VASOTEC, OMEPRAZOLE, THORAZINE, CORDARONE, PREVISCAN. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5624921-7
Neoral side effect was reported by a Physician from JAPAN on Jan 29, 2008. Male patient, 74 years of age, weighting 123.5 lb, was diagnosed with pemphigoid and was treated with Neoral. After drug was administered, patient experienced the following side effects: blister, blood osmolarity decreased, blood sodium decreased, condition aggravated, disease progression, erythema, hyponatraemia, inappropriate antidiuretic hormone secretion, pemphigoid. Neoral dosage: 150 MG/D. During the same period patient was treated with STEROIDS NOS, PREDONINE. Patient was hospitalized. Patient recovered.
Neoral Side Effects Report #5625296-X
Neoral side effect was reported by a Physician from JAPAN on Jan 29, 2008. Male patient, 74 years of age, weighting 123.5 lb, was diagnosed with pemphigoid and was treated with Neoral. After drug was administered, patient experienced the following side effects: blister, blood osmolarity decreased, blood sodium decreased, disease progression, erythema, hyponatraemia, inappropriate antidiuretic hormone secretion, white blood cell count increased. Neoral dosage: 150 MG/D. During the same period patient was treated with STEROIDS NOS, PREDONINE. Patient was hospitalized. Patient recovered.
Neoral Side Effects Report #5577657-5
Neoral side effect was reported by a Physician from JAPAN on Dec 25, 2007. Female patient was diagnosed with pemphigoid and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood sodium decreased, disease progression, hyponatraemia, inappropriate antidiuretic hormone secretion. Neoral dosage: 100 MG/D. During the same period patient was treated with STEROIDS NOS. Patient recovered.
Neoral Side Effects Report #5158478-4
Neoral side effect was reported by a Physician from JAPAN on Oct 13, 2006. Male patient, 32 years of age, was diagnosed with nephrotic syndrome and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, disease recurrence, nephrotic syndrome, renal vessel disorder. Neoral dosage: 100 MG/D (MEAN), ORAL. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
Neoral Side Effects Report #5334366-5
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on May 16, 2007. Female patient, child 12 years of age, was diagnosed with nephrotic syndrome and was treated with Neoral. After drug was administered, patient experienced the following side effects: coagulopathy, deep vein thrombosis
, diplopia, disease progression, headache , nephrotic syndrome, peritoneal dialysis, proteinuria, renal failure acute. Neoral dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized and became disabled. Patient recovered.Neoral Side Effects Report #5334367-7
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on May 16, 2007. Female patient, child 12 years of age, was diagnosed with nephrotic syndrome and was treated with Neoral. After drug was administered, patient experienced the following side effects: coagulopathy, deep vein thrombosis
, diplopia, disease progression, headache , nephrotic syndrome, peritoneal dialysis, proteinuria, renal failure acute. Neoral dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized and became disabled. Patient recovered.Neoral Side Effects Report #5381501-9
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2007. Female patient, child 12 years of age, was diagnosed with nephrotic syndrome and was treated with Neoral. After drug was administered, patient experienced the following side effects: coagulopathy, deep vein thrombosis
, diplopia, disease progression, headache , nephrotic syndrome, peritoneal dialysis, proteinuria, renal failure acute. Neoral dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized and became disabled. Patient recovered.Neoral Side Effects Report #5387330-4
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on July 06, 2007. Female patient, child 12 years of age, was diagnosed with nephrotic syndrome and was treated with Neoral. After drug was administered, patient experienced the following side effects: azotaemia, coagulopathy, deep vein thrombosis
, diplopia, disease progression, headache , kidney fibrosis, nephrotic syndrome, peritoneal dialysis. Neoral dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized and became disabled. Patient recovered.Neoral Side Effects Report #5715593-1
Neoral side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2008. Female patient, weighting 162.0 lb, was diagnosed with lymphoma
, transplant and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, nephritis, neutropenia, staphylococcal bacteraemia, stem cell transplant. Neoral dosage: 200MG EVERY 12 HRS. ORAL CONTINUE FOR 6-8 MONTHS TIL TAPERED OFF. Patient recovered.Neoral Side Effects Report #5228548-0
Neoral side effect was reported by a Physician from ARGENTINA on Jan 25, 2007. Male patient, 64 years of age, weighting 156.5 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: asthenia, disease progression, ear pain, granulomatous liver disease, hepatitis c , hepatitis cholestatic, hepatitis viral, herpes simplex , herpes zoster infection neurological. Neoral dosage: 150 MG DAILY. During the same period patient was treated with MEPREDNISONE, AZATHIOPRINE. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5175870-2
Neoral side effect was reported by a Physician from ARGENTINA on Oct 17, 2006. Male patient, 64 years of age, weighting 156.5 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: asthenia, disease progression, ear pain, granulomatous liver disease, hepatitis , hepatitis c , hepatitis cholestatic, herpes zoster infection neurological, influenza like illness. Neoral dosage: 150 MG DAILY. During the same period patient was treated with MEPREDNISONE, AZATHIOPRINE. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5528651-1
Neoral side effect was reported by a Physician from SPAIN on Nov 22, 2007. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: ascites, asthenia, cholestasis, disease progression, disease recurrence, fibrosis, graft dysfunction, hepatitis c . Neoral dosage: 300 MG, BID. During the same period patient was treated with INTERFERON GAMMA. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5565929-X
Neoral side effect was reported by a Physician from SPAIN on Dec 11, 2007. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: ascites, asthenia, autoantibody positive, cholestasis, concomitant disease progression, encephalopathy, fibrosis. Neoral dosage: 300 MG, BID. During the same period patient was treated with INTERFERON GAMMA. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5674174-9
Neoral side effect was reported by a Physician from SPAIN on Mar 13, 2008. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: ascites, asthenia, autoantibody positive, cholestasis, disease progression, encephalopathy, fibrosis, graft dysfunction. Neoral dosage: 300 MG, BID. During the same period patient was treated with INTERFERON GAMMA. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5674157-9
Neoral side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, neutropenia, pancytopenia, platelet count decreased, somnolence. Neoral dosage: 0.5MG QAM / 1MG QPM. During the same period patient was treated with VALCYTE, MYFORTIC. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #5677012-3
Neoral side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, neutropenia, pancytopenia, platelet count decreased, somnolence. Neoral dosage: 0.5MG QAM / 1MG QPM. During the same period patient was treated with VALCYTE, MYFORTIC. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #4565032-1
Neoral side effect was reported by a Physician from on Nov 27, 2004. Male patient, 47 years of age, weighting 172.0 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: ammonia increased, disease progression, hepatitis , jaundice , metabolic acidosis, renal failure acute, vomiting. Neoral dosage: 50 MG / DAY. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #4762827-6
Neoral side effect was reported by a Physician from ITALY on Nov 27, 2004. Male patient, 47 years of age, weighting 172.0 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: ammonia increased, disease progression, hepatitis , hepatorenal syndrome, jaundice , metabolic acidosis, renal failure acute, vomiting. Neoral dosage: 50 MG / DAY. Patient was hospitalized. Patient died on 02/12/2005.Neoral Side Effects Report #4811169-9
Neoral side effect was reported by a Physician from ITALY on Nov 27, 2004. Male patient, 47 years of age, weighting 172.0 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: ammonia increased, disease progression, hepatitis , hepatorenal syndrome, jaundice , metabolic acidosis, renal failure acute, vomiting. Neoral dosage: 50 MG / DAY. Patient was hospitalized. Patient died on 02/12/2005.Neoral Side Effects Report #4707071-3
Neoral side effect was reported by a Physician from SPAIN on Nov 18, 2004. Male patient, 39 years of age, weighting 154.3 lb, was diagnosed with liver transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: cholestasis, depressed level of consciousness, disease progression, encephalopathy, graft dysfunction, hepatic enzyme abnormal, korsakoff's psychosis non-alcoholic, lung infiltration, pneumonia aspiration. Neoral dosage: unknown. During the same period patient was treated with SIMULECT. Patient was hospitalized and became disabled. Patient died on 01/10/2005.Neoral Side Effects Report #5167908-3
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on Nov 09, 2005. Female patient, 63 years of age, was diagnosed with interstitial lung disease, bipolar disorder
and was treated with Neoral. After drug was administered, patient experienced the following side effects: beta 2 microglobulin increased, blood creatinine increased, blood urea increased, disease progression, herpes zoster, muscular weakness, pneumonia bacterial. Neoral dosage: 200 MG/D. During the same period patient was treated with LIMAS, PREDONINE. Patient recovered.Neoral Side Effects Report #5006799-8
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on Nov 09, 2005. Female patient, 63 years of age, was diagnosed with interstitial lung disease, bipolar disorder
and was treated with Neoral. After drug was administered, patient experienced the following side effects: beta 2 microglobulin increased, blood creatinine increased, blood urea increased, disease progression, psychiatric symptom, renal disorder. Neoral dosage: 200 MG/D. During the same period patient was treated with LIMAS, PREDONINE. Patient recovered.Neoral Side Effects Report #5840693-5
Neoral side effect was reported by a Health Professional from JAPAN on Aug 06, 2008. Male patient, 57 years of age, was diagnosed with interstitial lung disease and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, interstitial lung disease. Neoral dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, COTRIM, IMMUNE GLOBULIN INTRAVENOUS, ENDOXAN, PROGRAF. Patient died on 05/07/2008.
Neoral Side Effects Report #5844554-7
Neoral side effect was reported by a Health Professional from JAPAN on Aug 11, 2008. Male patient, 57 years of age, was diagnosed with interstitial lung disease and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood beta-d-glucan increased, disease progression, interstitial lung disease. Neoral dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, COTRIM, IMMUNE GLOBULIN INTRAVENOUS, ENDOXAN, PROGRAF. Patient died on 05/07/2008.
Neoral Side Effects Report #5909262-2
Neoral side effect was reported by a Consumer or non-health professional from JAPAN on Oct 03, 2008. Male patient, 57 years of age, was diagnosed with interstitial lung disease and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood beta-d-glucan increased, disease progression, interstitial lung disease. Neoral dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, COTRIM, IMMUNE GLOBULIN INTRAVENOUS, ENDOXAN, PROGRAF. Patient died on 05/07/2008.
Neoral Side Effects Report #5874555-4
Neoral side effect was reported by a Health Professional from JAPAN on Sept 04, 2008. Female patient, 49 years of age, was diagnosed with interstitial lung disease, systemic lupus erythematosus and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, cough, disease progression, endotracheal intubation, hypoventilation, interstitial lung disease, liver disorder, pneumomediastinum. Neoral dosage: 140 MG/ DAY. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, IMMUNE GLOBULIN INTRAVENOUS, PREDNISOLONE, CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE. Patient died on 07/01/2007.
Neoral Side Effects Report #5874562-1
Neoral side effect was reported by a Health Professional from JAPAN on Sept 04, 2008. Female patient, 49 years of age, was diagnosed with interstitial lung disease, systemic lupus erythematosus and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, cough, disease progression, endotracheal intubation, hypoventilation, interstitial lung disease, liver disorder, pneumomediastinum. Neoral dosage: 140 MG/ DAY. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, IMMUNE GLOBULIN INTRAVENOUS, PREDNISOLONE, CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE. Patient died on 07/01/2007.
Neoral Side Effects Report #5072769-7
Neoral side effect was reported by a Physician from JAPAN on June 06, 2006. Male patient was diagnosed with interstitial lung disease and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, peripheral nerve palsy. Neoral dosage: unknown. Patient was hospitalized. Patient died on 06/15/2006.
Neoral Side Effects Report #5839680-2
Neoral side effect was reported by a Physician from CANADA on Aug 07, 2008. Male patient, weighting 213.8 lb, was diagnosed with heart transplant
and was treated with Neoral. After drug was administered, patient experienced the following side effects: disease progression, malignant tumour excision, squamous cell carcinoma. Neoral dosage: 50 MG, BID. During the same period patient was treated with AZATHIOPRINE COMP. Patient died on 08/14/2003.Neoral Side Effects Report #4847835-9
Neoral side effect was reported by a Physician from JAPAN on Oct 28, 2005. Male patient, 72 years of age, weighting 103.6 lb, was diagnosed with erythrodermic psoriasis and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, contusion, depressed level of consciousness, diabetic complication, disease progression, fall
, hypercalcaemia, hypoglycaemia. Neoral dosage: 150 MG/EVERY OTHER DAY. During the same period patient was treated with ZYLORIC, BASEN, CELTECT, GLYCYRON, ATARAX, GASTER. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #4873257-0
Neoral side effect was reported by a Physician from JAPAN on Oct 28, 2005. Male patient, 72 years of age, weighting 103.6 lb, was diagnosed with erythrodermic psoriasis and was treated with Neoral. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, c-reactive protein increased, contusion, depressed level of consciousness, diabetic complication, disease progression, fall
, hypercalcaemia. Neoral dosage: 150 MG/EVERY OTHER DAY. During the same period patient was treated with ZYLORIC, BASEN, CELTECT, GLYCYRON, ATARAX. Patient was hospitalized. Patient recovered.Neoral Side Effects Report #4930245-3
Neoral side effect was reported by a Pharmacist from JAPAN on Jan 19, 2006. Female patient, weighting 99.21 lb, was diagnosed with dermatomyositis and was treated with Neoral. After drug was administered, patient experienced the following side effects: chest discomfort, disease progression, palpitations, tachycardia. Neoral dosage: 100 MG/D. During the same period patient was treated with PREDNISOLONE, PRORENAL, COTRIM. Patient recovered.
Neoral Side Effects Report #4547060-5
Neoral side effect was reported by a Physician from on Dec 16, 2004. Male patient, 74 years of age, weighting 123.5 lb, was diagnosed with aplastic anaemia and was treated with Neoral. After drug was administered, patient experienced the following side effects: abdominal pain
, blood creatinine increased, blood urea increased, disease progression, hepatic neoplasm malignant, hepatic rupture, intra-abdominal haemorrhage, renal impairment, therapeutic embolisation. Neoral dosage: 200 MG / DAY. During the same period patient was treated with NEUTROGIN, WARFARIN, LASIX. Patient was hospitalized. Patient died on 12/03/2004.Neoral Side Effects Report #5243452-X
Neoral side effect was reported by a Health Professional from JAPAN on Feb 13, 2007. Female patient, 23 years of age, was diagnosed with aplastic anaemia, stem cell transplant, liver disorder and was treated with Neoral. After drug was administered, patient experienced the following side effects: abdominal infection, aplastic anaemia, bone marrow disorder, bone marrow failure, chromosome abnormality, coma hepatic, disease progression, haemosiderosis, hepatic atrophy. Neoral dosage: 200 MG/DAY. During the same period patient was treated with NEUPOGEN, IRRADIATION, METHOTREXATE, PREDNISOLONE, ANTITHYMOCYTE IMMUNOGLOBULIN, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.
Neoral Side Effects Report #5245118-9
Neoral side effect was reported by a Health Professional from JAPAN on Feb 21, 2007. Female patient, 23 years of age, weighting 85.98 lb, was diagnosed with aplastic anaemia, stem cell transplant, liver disorder and was treated with Neoral. After drug was administered, patient experienced the following side effects: abdominal infection, aplastic anaemia, bone marrow disorder, bone marrow failure, chromosome abnormality, coma hepatic, disease progression, haemosiderosis, hepatic atrophy. Neoral dosage: 200 MG/DAY. During the same period patient was treated with NEUPOGEN, IRRADIATION, METHOTREXATE, PREDNISOLONE, ANTITHYMOCYTE IMMUNOGLOBULIN, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.
Neoral Side Effects Report #5247869-9
Neoral side effect was reported by a Health Professional from JAPAN on Feb 13, 2007. Female patient, 23 years of age, was diagnosed with aplastic anaemia, stem cell transplant, liver disorder and was treated with Neoral. After drug was administered, patient experienced the following side effects: abdominal infection, aplastic anaemia, bone marrow disorder, bone marrow failure, chromosome abnormality, coma hepatic, disease progression, haemosiderosis, hepatic atrophy. Neoral dosage: 200 MG/DAY. During the same period patient was treated with NEUPOGEN, IRRADIATION, METHOTREXATE, PREDNISOLONE, ANTITHYMOCYTE IMMUNOGLOBULIN, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.
Neoral Side Effects Report #4677459-8
Neoral side effect was reported by a Physician from on July 22, 2004. Male patient, 44 years of age, was diagnosed with cytomegalovirus infection
and was treated with Neoral. After drug was administered, patient experienced the following side effects: anaemia, bone lesion, cytomegalovirus infection , disease progression, graft versus host disease, hypercalcaemia, impaired healing, klebsiella sepsis. Neoral dosage: unknown. During the same period patient was treated with CYMEVENE, AREDIA, VINCRISTINE, VUMON, ENDOXAN. Patient was hospitalized and became disabled. Patient died on 11/21/2004.